The findings indicated that TTCS‐conditioned neutrophils significantly inhibited the cytotoxicity of tumor‐specific CD8+ T cells, and this effect could be effectively attenuated by blocking G‐CSF and/or GM‐CSF or using anti‐Mcl‐1 antibody on neutrophils (Figure 6E). The gene discussed is CD8A; the disease is neoplasm.